Editor’s note: This is an updating story. The United Nations Commission for Narcotic Drugs (CND) voted narrowly Dec. 2 to remove medicinal cannabis from Schedule IV of a 1961 treaty on narcotic drugs. The CND, an organization based in Vienna with members from 53 different countries, voted on six... Read more
Gene-editing cannabis biotech to breed hemp seeds in San Diego
An Israeli company applying gene-editing tools to cannabis has bought a farm in San Diego and plans to start producing hemp seeds. CanBreed says it acquired 3.5 acres near San Diego. CanBreed is the first biotech in cannabis to commercially license a gene-editing technology called CRISPR. The technology was... Read more
BREAKING: European Commission reverses course, says CBD should not be regulated as a narcotic
Want to learn more about cannabis regulations in Europe? Check out the Europe Market Forum at MJBizCon, available on demand. Makers of CBD foods and supplements no longer face the prospect of a blanket ban in Europe after the European Commission revised its preliminary stance that CBD should be... Read more
Cannabis Trademark Protection in Brazil

An appeals court in Brazil is set to consider the issue of cannabis-related trademarks, and in particular their registrability under the country’s Intellectual Property Law (LPI), which forbids the registration of marks “contrary to morals and good customs” (Article 124, III). One of the key issues at the intersection of cannabis law and cannabis business

The post Cannabis Trademark Protection in Brazil appeared first on Harris Bricken.

Read more
What is the Right Way to Compensate Key Cannabis Executives and Employees? With Stock or Options?

This is the season of the year where cannabis business owners start to take a hard look at their end of year finances to decipher how profitable the company has been and whether and how their employees and other key personnel should share in that profit alongside the owners. Some marijuana and hemp employers do

The post What is the Right Way to Compensate Key Cannabis Executives and Employees? With Stock or Options? appeared first on Harris Bricken.

Read more
The MORE Act Will NOT Legalize Cannabis Nationwide. Not Like You’re Thinking.

We have spilled a good bit of ink on this blog writing about the MORE Act (Marijuana Opportunity and Expungement Act) which is finally headed to a floor vote in the House, probably tomorrow, December 3. The MORE Act ends federal marijuana prohibition and the criminalization of cannabis by descheduling marijuana from the Controlled Substances

The post The MORE Act Will NOT Legalize Cannabis Nationwide. Not Like You’re Thinking. appeared first on Harris Bricken.

Read more
TILT Holdings Completes Sale of Blackbird
Ryan Allway December 2nd, 2020 December 01, 2020 07:30 ET | Source: TILT Holdings Inc. PHOENIX, Dec. 01, 2020 (GLOBE NEWSWIRE) — TILT Holdings Inc. (“TILT” or the “Company”) (CSE: TILT) (OTCQB: TLLTF), a provider of business solutions to the global cannabis industry, announced today the completion of its previously announced sale (the “Blackbird Sale”) of... Read more
Vext Announces Exercise and Closing of Over-Allotment Option
Ryan Allway December 2nd, 2020 VANCOUVER, BC, Dec. 1, 2020 /CNW/ – Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) (“VEXT” or the “Company”), a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation and marketing to build a profitable multi-state footprint, is pleased to announce that further to the short form... Read more
Ryan Allway December 2nd, 2020 TORONTO, Dec. 1, 2020 /PRNewswire/ – Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQB:CTABF) (FRA:TBF1.F) (the “Company” or “Canntab“), the leading innovator in cannabinoid and terpene blends in hard pill form for medical and therapeutic applications, is pleased to announce that it has completed its first delivery of two (2)... Read more
PharmaTher Expands Research Partnership with University Health Network For Development of Digital Therapeutics Platform
Ryan Allway December 2nd, 2020 Psychedelics PharmaTher Inc., a wholly-owned subsidiary of Newscope Capital Corporation (“PharmaTher”) (CSE: PHRM) (OTC Pink: PHRRF) and a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals, is pleased to announce that it has amended its sponsored research agreement with... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )